Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 3/13/2026Veristat Expands Regulatory and Clinical Trial Services for Chinese Dr...
  • 3/13/2026Jeyou Pharma Raises About CNY 2B in Series A to Advance Clinical Pipel...
  • 3/12/2026Almirall Expands China Presence, Seeks More Dermatology Partnerships
  • 3/12/2026Pamplona and Coherent Partner on Targeted Protein Degradation Conjugat...
  • 3/12/2026Eli Radiopharma Raises ~CNY 100M to Advance Theranostics Pipeline
  • 3/11/2026Eli Lilly Plans $3B China Manufacturing Investment, Partners With Phar...
  • 3/11/2026Peak Perform Innova Raises ~CNY 100M Angel Round to Advance PPI Drug D...
  • 3/11/2026Erasca Expands License With Joyo Pharmatech to Secure Global Rights to...
  • 3/10/2026Haleon Expands Oral-Health Presence in China as Western Brands Struggl...
  • 3/10/2026China Patent Expiry and New GLP-1 Drugs Spark Global Obesity Drug Comp...
  • 3/10/2026Hutchmed Withdraws Tazverik from China Following Safety Concerns
  • 3/9/2026Rapport Licenses Seizure Drug Candidate to Tenacia in Greater China
  • 3/9/2026iCamuno Biothera Raises Over CNY 100M in Series A3 to Advance iPSC Cel...
  • 3/4/2026Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...
  • 3/4/2026Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of Hong Kong Listin...
  • 3/4/2026Antengene Strikes $1.1B+ CD19 T-Cell Engager Deal with UCB
  • 3/4/2026Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...
  • 3/3/2026Clickmab Biotech Secures Seed+ Funding to Boost AI Antibody Design Pla...
  • 3/3/2026Rallybio to Merge with Candid Therapeutics in $505M-Funded Reverse Mer...
  • 3/3/2026Prolium Launches with $50M to Advance China-Licensed T-Cell Engager in...
  • 3/2/2026QL Biopharm Raises Over CNY 500M in Series C Led by OrbiMed
  • 3/2/2026NMPA Grants Conditional Approval to Sosimerasib for KRAS G12C-Mutant N...
  • 3/2/2026WuXi XDC Partners With Earendil Labs on Next-Generation ADC Platform
  • 2/28/2026bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
  • 2/27/2026Duality Reports Updated DB-1311/BNT324 Data at ASCO GU 2026
  • 2/26/2026China's Biopharma Boom Attracts Global Investment Amid Innovation Surg...
  • 2/25/2026CASI Pharma to Be Delisted from Nasdaq, Shares to Move to OTC Market
  • 2/25/2026Prodegre Closes Angel+ Round to Advance CNS Pipeline and ATLAS™ Platf...
  • 2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...
  • 2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...
  • Page:1/26 Total number of articles:752: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group